Investigational Drug Lowers Tourette Relapse Risk in Kids

(MedPage Today) -- Children and adolescents with Tourette syndrome had a lower risk of relapses with investigational ecopipam, a phase III randomized withdrawal study showed. Compared with placebo, ecopipam reduced relapse risk in 90 pediatric...
Source
MedPage Today
Opens original article in a new tab



